Unleashing the power of anti-HER2 therapies in metastatic colorectal cancer: paving the way for a brighter future
Article in ESMO Gastrointestinal Oncology (March 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Whole slide image features predict pathologic complete response and poor clinical outcomes in triple-negative breast cancer
Article in Pathology - Research and Practice (April 2023)
Non-phosphorylated Tyr-1248 form of human epidermal growth factor receptor 2 (HER2) predicts resistance to trastuzumab therapy and poor disease-free survival of HER2-positive breast cancer patients
Article in Croatian Medical Journal (April 2022)